ALIGN TECHNOLOGY INC (ALGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALGN | Chair of Compensation and Human Capital Committee | 60 | ["CEO and Chairman of the Board at Exact Sciences Corp. (2014-2026)","President and CEO at Third Wave Technologies, Inc. (2005-2008)","General Counsel at Third Wave Technologies, Inc. (2004-2005)","Various Leadership Positions at GE Healthcare","Extensive experience in healthcare and molecular diagnostics industries"] | ["Compensation and Human Capital Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EXAS | President, Chief Executive Officer, and Chairman of the Board of Directors of Exact Sciences Corporation; Chairman, President and Chief Executive Officer | 59 | ["Extensive business knowledge", "Legal and executive leadership experience", "20 years in the healthcare and health technology space", "Chief Executive Officer of Exact Sciences and Third Wave Technologies", "Experience in developing diagnostic tests", "Collaborative research efforts leading to the development of Cologuard"] | [] | 2025 |
Biography sourced from the proxy statement filing.
Age: 60 Director Since: 2023 Roles: Independent Director; Chair of Compensation and Human Capital Committee Committees: Compensation and Human Capital Committee Election Term: 2026-2027 Experience: 2009 - 2026 CEO and Chairman of the Board (2014), Exact Sciences Corp. (molecular diagnostics company) 2005 - 2008 President and CEO, Third Wave Technologies, Inc. (molecular diagnostics company) 2004 - 2005 General Counsel, Third Wave Technologies, Inc. (molecular diagnostics company) Prior Various Leadership Positions at GE Healthcare (medical technology company) Other Board Positions Exact Sciences Corp. (2014-2026) Fuze Health (2025-present) Adaptive Biotechnologies Corporation (2019-2023) Epizyme, Inc. (2017-2022) CM Life Sciences II Inc. (2021) SomaLogic, Inc. (2021) Arya Sciences Acquisition Corp. (2018-2020) Notable Experience and Key Board Contributions Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries. At Exact Sciences, Mr. Conroy helped to develop Cologuard and the company has grown to $2.76B in revenue while serving 4.5 million patients. At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients. Education B.S. in Electrical Engineering from Michigan State University J.D. from the University of Michigan Law School